Latest Investor Confidence News

Wrkr Ltd has completed a $15 million placement to fund key growth initiatives and compliance upgrades ahead of new superannuation regulations.

Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.

Finexia Financial Group has resumed trading following announcements of a significant business disposal and new executive appointments, signaling a pivotal restructuring phase.

360 Capital Mortgage REIT (ASX – TCF) reported a robust FY25 with a 38.4% increase in distributions and a 74.6% rise in operating profit, underpinned by a high-quality fixed-rate loan portfolio and successful capital raisings.

360 Capital Mortgage REIT (TCF) reported a robust FY25 with a 21.5% total unitholder return and significant capital raising activity that doubled its market capitalization.

Classic Minerals has completed a design study for a 250,000 tonnes per annum Carbon-in-Leach gold processing plant at Forrestania, appointing IPS Global as EPCM contractor and outlining a scalable growth strategy.

Emu NL has lodged a formal review application against the Takeovers Panel's recent variation of orders, signaling continued regulatory tension in its takeover proceedings.

Silex Systems has raised $130 million through an institutional placement to advance its SILEX uranium enrichment technology in the US, bolstering its financial position through FY2028.

ASX has revealed it expects to incur an additional $25 million to $35 million in operating expenses in FY26 due to the ongoing ASIC compliance inquiry. Despite this, the company remains committed to its five-year strategy focused on technology and risk management.

SportsHero Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed price-sensitive information and ongoing compliance with disclosure rules.

BMG Resources has secured $600,000 through a strategic share placement to advance its Western Australian gold projects, focusing on a scoping study at Abercromby and further drilling at Bullabulling.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.